Skip to content

Legacy Reserves LGCY Number of Exercisable Options

Number of Exercisable Options at other companies

BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
2.9M+96.6%

Other financials

Income statement

See full
Revenue$21.4M+15.0%
Operating income$3.9M+7.6%
Net income$3.0M+7.5%
EPS (diluted)$0.22+4.8%

Balance sheet

See full
Cash & equivalents$21.7M+25.1%
Total debt$15.5M-13.3%
Total equity$49.5M+26.1%
Total assets$75.5M+12.5%

Cash flow

See full
Operating cash flow$764.4K-16.8%
CapEx$248.6K-22.8%
Free cash flow$515.8K-13.6%

Valuation

See full
Market cap$147.9M+3.8%
Enterprise value$141.69M+1.3%
P/E17.4×-1.5×
P/S1.9×-0.3×

Profitability

See full
Operating margin14.4%-0.6pp
Net margin10.9%-1.4pp
FCF margin6.1%

Returns & leverage

See full
Return on equity19.1%-5.6pp
Debt / equity0.3×-0.1×
Current ratio3.4×+0.7×

Where this comes from

Reported directly by Legacy Reserves in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Legacy Reserves’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Legacy Reserves's number of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Legacy Reserves's number of exercisable options?
Legacy Reserves (LGCY) reported number of exercisable options of 1.6M in Q1 2026.
How has Legacy Reserves's number of exercisable options changed year-over-year?
Legacy Reserves's number of exercisable options increased by 11.2% year-over-year, from 1.5M to 1.6M.
What does number of exercisable options mean?
The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.